Regulation 2 Amendment of regulation 2(1) of the principal regulations
Regulation 2(1) of the principal regulations (interpretation) shall be amended by adding—
immediately after the definition of “advertisement” the following definitions:—
““BCG” means the bacillus of Calmette and Guerin;
“BCG vaccine” means a vaccine that is a preparation of the bacteria in a living pure culture of a strain of the bacillus of Calmette and Guerin; ”;
immediately after the definition of “medicinal product” the following definitions:—
““parenteral administration” means administration by breach of the skin or mucous membrane;
“serum” means a fluid fraction of coagulated blood;
“smallpox vaccine” means a vaccine that is a preparation of an infective vaccinia virus;
“toxins” means substances used in the diagnosis, prevention or treatment of disease consisting wholly or partly of poisonous substances derived from specific micro-organisms, plants or animals;
“vaccines” means antigenic substances which consist wholly or partly of—
- (i)
any micro-organisms, viruses or other organisms in any state,
- (ii)
any toxins of microbial origin which have been detoxified (toxoids), or
- (iii)
any extracts or derivatives of any micro-organisms or of any viruses,
being substances which, when administered to human beings or animals, are used for the prevention or treatment of specific diseases;”